Brief: VolitionRX Limited Says Q3 Cash And Cash Equivalents As Of September 30, 2019 Totaled $19.7 Million
12/11/2019 21:50
Nov 12 (Reuters) - VolitionRX Ltd VNRX.A :
* VOLITIONRX LIMITED ANNOUNCES THIRD QUARTER 2019 FINANCIAL
RESULTS AND BUSINESS UPDATE
* VOLITIONRX LTD - CASH AND CASH EQUIVALENTS AS OF SEPTEMBER
30,
2019 TOTALED $19.7 MILLION
Source text for Eikon: ID:nPn8SyNTGa
Further company coverage: VNRX.A
((Reuters.Briefs@thomsonreuters.com;))
Recent news on VolitionRX
See all newsBrief: Volitionrx -Files Preliminary Prospectus For 10,006,360 Shares Of Common Stock Offered By Selling Stockholder - SEC Filing
Brief: Volitionrx - Advances Nu.Q Nets Platform Towards Commercialization
Brief: VolitionRX Limited Announces First Quarter 2026 Financial Results
Brief: Volition Reports Breakthrough In Liquid Biopsy Achievement Of Over 99% Purity In Isolating Cancer Dna
Brief: Volition Announces First Ever Automated Nu.Q® Vet Cancer Test With Fujifilm Vet Systems